Sumitomo Mitsui DS Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $81.7M | Buy |
324,551
+3,394
| +1% | +$730K | 0.56% | 42 |
|
|
2026
Q1 | $69.8M | Buy |
321,157
+4,634
| +1% | +$1.03M | 0.56% | 38 |
|
|
2025
Q4 | $72.3M | Buy |
316,523
+30,032
| +10% | +$6.84M | 0.57% | 38 |
|
|
2025
Q3 | $66.3M | Buy |
286,491
+5,571
| +2% | +$1.13M | 0.54% | 41 |
|
|
2025
Q2 | $52.1M | Buy |
280,920
+8,090
| +3% | +$1.5M | 0.47% | 48 |
|
|
2025
Q1 | $57.2M | Buy |
272,830
+13,560
| +5% | +$2.64M | 0.58% | 38 |
|
|
2024
Q4 | $46.1M | Buy |
259,270
+32,467
| +14% | +$5.97M | 0.47% | 45 |
|
|
2024
Q3 | $44.8M | Buy |
226,803
+21,790
| +11% | +$4.07M | 0.48% | 43 |
|
|
2024
Q2 | $35.2M | Buy |
205,013
+6,881
| +3% | +$1.14M | 0.42% | 49 |
|
|
2024
Q1 | $36.1M | Buy |
198,132
+9,390
| +5% | +$1.62M | 0.45% | 46 |
|
|
2023
Q4 | $29.2M | Buy |
188,742
+413
| +0.2% | +$60.2K | 0.38% | 56 |
|
|
2023
Q3 | $28.1M | Buy |
188,329
+8,604
| +5% | +$1.26M | 0.44% | 52 |
|
|
2023
Q2 | $24.2M | Buy |
179,725
+29,437
| +20% | +$4.32M | 0.37% | 57 |
|
|
2023
Q1 | $24M | Buy |
150,288
+8,159
| +6% | +$1.25M | 0.43% | 53 |
|
|
2022
Q4 | $23M | Buy |
142,129
+4,803
| +3% | +$736K | 0.47% | 52 |
|
|
2022
Q3 | $18.4M | Buy |
137,326
+8,219
| +6% | +$1.18M | 0.42% | 56 |
|
|
2022
Q2 | $19.8M | Sell |
129,107
-11,751
| -8% | -$1.8M | 0.47% | 50 |
|
|
2022
Q1 | $22.8M | Buy |
140,858
+83
| +0.1% | +$12.1K | 0.48% | 44 |
|
|
2021
Q4 | $19.1M | Buy |
140,775
+3,812
| +3% | +$450K | 0.4% | 63 |
|
|
2021
Q3 | $14.8M | Sell |
136,963
-1,201
| -0.9% | -$137K | 0.35% | 64 |
|
|
2021
Q2 | $15.6M | Sell |
138,164
-1,993
| -1% | -$224K | 0.37% | 58 |
|
|
2021
Q1 | $15.2M | Buy |
140,157
+1,674
| +1% | +$179K | 0.4% | 57 |
|
|
2020
Q4 | $14.8M | Buy |
138,483
+2,636
| +2% | +$253K | 0.42% | 58 |
|
|
2020
Q3 | $11.9M | Sell |
135,847
-2,408
| -2% | -$227K | 0.38% | 66 |
|
|
2020
Q2 | $13.6M | Buy |
138,255
+12,525
| +10% | +$1.1M | 0.47% | 50 |
|
|
2020
Q1 | $9.58M | Sell |
125,730
-22,733
| -15% | -$1.94M | 0.39% | 57 |
|
|
2019
Q4 | $13.1M | Sell |
148,463
-6,554
| -4% | -$544K | 0.45% | 51 |
|
|
2019
Q3 | $11.7M | Buy |
155,017
+9,190
| +6% | +$630K | 0.44% | 50 |
|
|
2019
Q2 | $10.6M | Buy |
145,827
+6,669
| +5% | +$524K | 0.43% | 51 |
|
|
2019
Q1 | $11.2M | Buy |
139,158
+17,444
| +14% | +$1.43M | 0.19% | 121 |
|
|
2018
Q4 | $11.2M | Sell |
121,714
-15,600
| -11% | -$1.37M | 0.2% | 107 |
|
|
2018
Q3 | $13M | Sell |
137,314
-4,957
| -3% | -$470K | 0.2% | 108 |
|
|
2018
Q2 | $13.2M | Sell |
142,271
-5,798
| -4% | -$566K | 0.2% | 103 |
|
|
2018
Q1 | $14M | Sell |
148,069
-18,542
| -11% | -$2.04M | 0.21% | 103 |
|
|
2017
Q4 | $16.1M | Buy |
166,611
+10,617
| +7% | +$1M | 0.24% | 95 |
|
|
2017
Q3 | $13.9M | Sell |
155,994
-4,458
| -3% | -$339K | 0.22% | 108 |
|
|
2017
Q2 | $11.6M | Sell |
160,452
-8,780
| -5% | -$590K | 0.19% | 119 |
|
|
2017
Q1 | $11M | Sell |
169,232
-23,880
| -12% | -$1.5M | 0.19% | 120 |
|
|
2016
Q4 | $12.1M | Sell |
193,112
-35,004
| -15% | -$2.14M | 0.23% | 117 |
|
|
2016
Q3 | $14.4M | Sell |
228,116
-26,888
| -11% | -$1.74M | 0.31% | 103 |
|
|
2016
Q2 | $15.8M | Buy |
255,004
+28,276
| +12% | +$1.72M | 0.48% | 60 |
|
|
2016
Q1 | $12.9M | Sell |
226,728
-9,469
| -4% | -$528K | 0.4% | 69 |
|
|
2015
Q4 | $14M | Sell |
236,197
-17,767
| -7% | -$1.02M | 0.47% | 61 |
|
|
2015
Q3 | $13.8M | Buy |
253,964
+31,633
| +14% | +$2.06M | 0.47% | 54 |
|
|
2015
Q2 | $14.9M | Sell |
222,331
-4,925
| -2% | -$322K | 0.47% | 56 |
|
|
2015
Q1 | $13.3M | Sell |
227,256
-60,589
| -21% | -$3.66M | 0.4% | 73 |
|
|
2014
Q4 | $18.8M | Sell |
287,845
-16,887
| -6% | -$1.06M | 0.58% | 42 |
|
|
2014
Q3 | $17.6M | Sell |
304,732
-16,300
| -5% | -$905K | 0.54% | 46 |
|
|
2014
Q2 | $18.1M | Sell |
321,032
-10,046
| -3% | -$527K | 0.52% | 46 |
|
|
2014
Q1 | $17M | Sell |
331,078
-36,592
| -10% | -$1.85M | 0.5% | 45 |
|
|
2013
Q4 | $19.4M | Sell |
367,670
-54,907
| -13% | -$2.7M | 0.56% | 43 |
|
|
2013
Q3 | $18.9M | Buy |
422,577
+96,878
| +30% | +$4.29M | 0.54% | 47 |
|
|
2013
Q2 | $13.5M | Buy |
+325,699
| New | +$14.2M | 0.38% | 64 |
|
Other funds holding ABBV
Sumitomo Mitsui DS Asset Management's ABBV Position: Q2 2026 in Review
Sumitomo Mitsui DS Asset Management increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $730K and bringing the position to 324,551 shares worth $81.7M. The position accounts for 0.56% of the portfolio, ranked #42.
Sumitomo Mitsui DS Asset Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Sumitomo Mitsui DS Asset Management held 324,551 shares of AbbVie worth $81.7M as of Q2 2026.
- Sumitomo Mitsui DS Asset Management bought 3,394 AbbVie shares in Q2 2026, an estimated $730K.
- AbbVie made up 0.56% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #42 holding.
- Sumitomo Mitsui DS Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.